J Clin Oncol 2008, 26:848–855.PubMedCrossRef 35. Jakobsen A, Mortensen JP, Bisgaard C, Lindebjerg J, Rafaelsen SR, this website Bendtsen VO: A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial. Int J Colorectal Dis 2008, 23:251–255.PubMedCrossRef 36. Mutter R, Lu B, Carbone DP, Csiki I, Moretti L, Johnson DH, Morrow JD, Sandler AB, Shyr Y, Ye F, Choy H: A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer. Clin Cancer Res 2009, 15:2158–2165.PubMedCrossRef 37. Dohadwala

M, Yang SC, Luo J, Sharma S, Batra RK, Huang M, Lin Y, Goodglick L, Krysan K, Fishbein MC, Ipatasertib in vitro Hong L, Lai C, Cameron RB, Gemmill RM, Drabkin HA, Dubinett SM: Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E (2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res 2006, 66:5338–5345.PubMedCrossRef 38. Noda M, Tatsumi Y, Tomizawa M, Takama T, Mitsufuji S, Sugihara H, Kashima K, Hattori T: Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal

cell lines. J Gastroenterol 2002, 37:896–904.PubMedCrossRef see more 39. Bozzo F, Bassignana A, Lazzarato L, Boschi D, Gasco A, Bocca C, Miglietta A: Novel RVX-208 nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth. Chem Biol Interact 2009, 182:183–190.PubMedCrossRef 40. Sitarz R, Leguit RJ, de Leng WW, Morsink FH, Polkowski WP, Maciejewski R, Offerhaus GJ, Milne AN: Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines. Cell Oncol 2009, 31:475–485.PubMed 41. Jang TJ, Cha WH, Lee KS: Reciprocal correlation between the expression of cyclooxygenase-2

and E-cadherin in human bladder transitional cell carcinomas. Virchows Arch 2010, 457:319–328.PubMedCrossRef 42. Okamoto A, Shirakawa T, Bito T, Shigemura K, Hamada K, Gotoh A, Fujisawa M, Kawabata M: Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo. Urology 2008, 71:156–160.PubMedCrossRef 43. Adhim Z, Matsuoka T, Bito T, Shigemura K, Lee KM, Kawabata M, Fujisawa M, Nibu K, Shirakawa T: In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines. Br J Cancer 2011, 105:393–402.PubMedCentralPubMedCrossRef 44.